Preferred Name |
flibanserin |
|
Synonyms |
1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one |
|
ID |
http://purl.bioontology.org/ontology/MESH/C098107 |
|
altLabel |
1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one Addyi BIMT 17 BIMT-17 |
|
cui |
C0386752 C0754280 C4051421 |
|
HM |
D001562 |
|
Inverse of RB |
37JK4STR6Z 0 |
|
Mapped to | ||
MDA |
20140801 |
|
MeSH Frequency |
166 |
|
MMR |
20161003 |
|
notation |
C098107 |
|
prefLabel |
flibanserin |
|
RR |
167933-07-5 (flibanserin) |
|
SC |
1 |
|
Scope Statement |
a 5-HT(2A) receptor antagonist and 5-HT(1A) receptor agonist in rat cerebral cortex; structure given in first source |
|
SRC |
Naunyn Schmiedebergs Arch Pharmacol 1995 Sep;352(3):276-82 |
|
TERMUI |
T000908682 T287771 T287772 T287773 T287774 |
|
TH |
NLM (1996) NLM (2016) FDA SRS (2013) USAN (19XX) INN (19XX) |
|
tui |
T109 T121 |
Create mapping